INSP - NYSE
Inspire Medical Systems, Inc.
$40.47
-0.27%Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
At a Glance
Live Snapshotinsp
Research Development Expenses
Last Annual Value
103.17M
3-Year CAGR
15%
5-Year CAGR
32%
10-Year CAGR
31%
Inspire Medical Systems, Inc. Competitors Analysis of research-development-expenses
| Company | research-development-expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Inspire Medical Systems, Inc. NYSE:INSP | 103.17M | -4.0% | 22.5% | 30.7% | |
 Premier, Inc. NASDAQ:PINC | 2.63M | -16.6% | -4.6% | -1.0% | |
 Artivion, Inc. NYSE:AORT | 30.99M | 2.6% | -2.7% | 8.7% | |
 89bio, Inc. NASDAQ:ETNB | 345.04M | 41.3% | 37.5% | N/A | |
 LeMaitre Vascular, Inc. NASDAQ:LMAT | 14.14M | -5.9% | 3.7% | 8.7% | |
 PROCEPT BioRobotics Corporation NASDAQ:PRCT | 71.28M | 13.7% | 30.3% | N/A | |
 Addus HomeCare Corporation NASDAQ:ADUS | 0.00 | N/A | N/A | N/A | |
 Integer Holdings Corporation NYSE:ITGR | 46.35M | -9.2% | -2.3% | -0.3% | |
 Ardent Health Partners, LLC NYSE:ARDT | 0.00 | N/A | N/A | N/A | |
 Arcus Biosciences, Inc. NYSE:RCUS | 523.00M | 15.4% | 15.3% | 43.4% | |
 Brookdale Senior Living Inc. NYSE:BKD | 0.00 | N/A | N/A | N/A |
Inspire Medical Systems, Inc. Fair Value Envelope
Related Guides
Continue your INSP research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.